ACRIX | BLNAX | ACRIX / BLNAX | |
Total Expense Ratio | 1.18 | 1.13 | 104% |
Annual Report Gross Expense Ratio | 1.18 | 1.13 | 104% |
Fund Existence | 9 years | 9 years | - |
Gain YTD | 12.780 | 10.679 | 120% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 10000000 | 2500 | 400,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.43B | 436M | 327% |
Annual Yield % from dividends | 0.49 | 1.34 | 36% |
Returns for 1 year | 1.21 | -1.75 | -69% |
Returns for 3 years | 37.07 | 25.41 | 146% |
Returns for 5 years | 40.16 | 26.97 | 149% |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
PJP | 95.65 | 1.25 | +1.32% |
Invesco Pharmaceuticals ETF | |||
FXC | 70.03 | 0.04 | +0.06% |
Invesco CurrencyShares® Canadian Dollar | |||
KDRN | 23.27 | N/A | N/A |
Kingsbarn Tactical Bond ETF | |||
FWD | 103.51 | -0.12 | -0.12% |
AB Disruptors ETF | |||
NEWZ | 28.35 | -0.04 | -0.13% |
EA Series Trust StockSnips AI-Powered Sentiment US All Cap ETF |